Lipocine: Fourth Quarter Financial Results Overview

Lipocine Inc. Announces Fourth Quarter Financial Results

Lipocine Inc., headquartered in Salt Lake City, disclosed a net loss of $2.4 million for the fourth quarter.

During this period, the company reported a per-share loss of 34 cents.

The specialty pharmaceutical firm generated $1.1 million in revenue for the quarter.

For the full fiscal year, Lipocine recorded a total loss of $9.6 million, translating to $1.69 per share, with annual revenue reaching $2 million.